Global Sterile Injectables Market - Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders - Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)"

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4 Sterile Injectables Outlook

5 Global Sterile Injectables: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global  Sterile  Injectables Market - Segment Analysis

6.1 Global  Sterile  Injectables Market - By Molecule Type
6.1.1 By Type, 2017 (%)
6.1.2 By Type, 2023 (%)
6.2 Global Biologic Sterile Injectables Market, By Value (2013-2023)
6.3 Global Small Molecule Sterile Injectables Market, By Value (2013-2023)

6.4 Global  Sterile  Injectables Market - By Biologic Drug Type 
6.4.1 By Type, 2017 (%)
6.4.2 By Type, 2023 (%)
6.5 Global Monoclonal Antibody Sterile Injectables Market, By Value (2013-2023)
6.6 Global Insulin  Sterile Injectables Market, By Value (2013-2023)
6.7 Global Vaccines Sterile Injectables Market, By Value (2013-2023)
6.8 Global Fusion Proteins Sterile Injectables Market, By Value (2013-2023)
6.9 Global Immunoglobulins Sterile Injectables Market, By Value (2013-2023)
6.10 Global  Others Biologic Sterile Injectables Market, By Value (2013-2023)

6.11 Global  Sterile  Injectables Market - By Indication
6.11.1 By Indication, 2017 (%)
6.11.2 By Indication, 2023 (%)
6.12 Global  Sterile Injectables For Oncological Disorders Market, By Value (2013-2023)
6.13 Global  Sterile Injectables For Infectious Disorders Market, By Value (2013-2023)
6.14 Global Sterile Injectables For Metabolic Disorders Market, By Value (2013-2023)
6.15 Global  Sterile Injectables For Cardiovascular Disorders Market, By Value (2013-2023)
6.16 Global  Sterile Injectables For Neurological  Disorders Market, By Value (2013-2023)
6.17 Global  Sterile Injectables For Musculoskeletal Disorders Market, By Value (2013-2023)
6.18 Global  Others Indication Sterile Injectables Market, By Value (2013-2023)

6.19 Global  Sterile  Injectables Market - By Distribution Channel 
6.19.1 By Distribution Channel, By Value, 2017 (%)
6.19.2 By Distribution Channel, By Value, 2023 (%)
6.20 Global Hospital Pharmacy Sterile Injectables  Market, By Value (2013-2023)
6.21 Global  Retail Pharmacy Sterile Injectables  Market, By Value (2013-2023)
6.22 Global Ecommerce  Sterile Injectables  Market, By Value (2013-2023)

7. Global Sterile Injectables Market: Regional Analysis
7.1 Global Sterile Injectables Market Size, By Region: Breakdown (%)
7.1.1 By Region, By Value, 2017 (%)
7.1.2 By Region, By Value, 2023 (%)

7.2 North America  Sterile Injectables Market: An Analysis
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.2.3 By Molecule Type, By Value (2013-2023)
7.2.4 By Biologic Drug Type, By Value (2013-2023)
7.2.5 By Indication, By Value (2013-2023)
7.2.6 By Distribution Channel, By Value (2013-2023)
7.3 North America Sterile Injectables Market, Country Share Analysis:  2017(%) and 2023F (%)
7.3.1 U.S Sterile Injectables Market, By Value (2013-2023)
7.3.2 U.S Sterile Injectables Market, By Indication, By Value (2013-2023)
7.3.3 Canada Sterile Injectables Market, By Value (2013-2023)
7.3.4 Canada Sterile Injectables Market, By Indication, By Value (2013-2023)

7.4 Europe  Sterile Injectables Market: An Analysis
7.4.1 By Value (2013-2017)
7.4.2 By Value (2018-2023)
7.4.3 By Molecule Type, By Value (2013-2023)
7.4.4 By Biologic Drug Type, By Value (2013-2023)
7.4.5 By Indication, By Value (2013-2023)
7.4.6 By Distribution Channel, By Value (2013-2023)
7.5 Europe Sterile Injectables Market, Country Share Analysis:  2017(%) and 2023F (%)
7.5.1 Germany Sterile Injectables Market, By Value (2013-2023)
7.5.2 Germany Sterile Injectables Market, By Indication, By Value (2013-2023)
7.5.3 United Kingdom Sterile Injectables Market, By Value (2013-2023)
7.5.4 United Kingdom Injectables Market, By Indication, By Value (2013-2023)
7.5.5 Rest of Europe Sterile Injectables Market, By Value (2013-2023)

7.7 APAC  Sterile Injectables Market: An Analysis
7.7.1 By Value (2013-2017)
7.7.2 By Value (2018-2023)
7.7.3 By Molecule Type, By Value (2013-2023)
7.7.4 By Biologic Drug Type, By Value (2013-2023)
7.7.5 By Indication, By Value (2013-2023)
7.7.6 By Distribution Channel, By Value (2013-2023)
7.8 APAC Sterile Injectables Market, Country Share Analysis:  2017(%) and 2023F (%)
7.8.1 China Sterile Injectables Market, By Value (2013-2023)
7.8.2 China Sterile Injectables Market, By Indication, By Value (2013-2023)
7.8.3 Japan Sterile Injectables Market, By Value (2013-2023)
7.8.4 Japan Injectables Market, By Indication, By Value (2013-2023)
7.8.5 India Sterile Injectables Market, By Value (2013-2023)
7.8.6 India Injectables Market, By Indication, By Value (2013-2023)
7.8.7 Rest of APAC Sterile Injectables Market, By Value (2013-2023)

7.9 Rest of the World  Sterile Injectables Market: An Analysis
7.9.1 By Value (2013-2017)
7.9.2 By Value (2018-2023)
7.9.3 By Molecule Type, By Value (2013-2023)
7.9.4 By Biologic Drug Type, By Value (2013-2023)
7.9.5 By Distribution Channel, By Value (2013-2023)
7.10 Rest of the World Sterile Injectables Market, Country Share Analysis:  2017(%) and 2023F (%)
7.5.1 Brazil Sterile Injectables Market, By Value (2013-2023)
7.5.2 Brazil Sterile Injectables Market, By Indication, By Value (2013-2023)
7.5.3 Saudi Arabia Sterile Injectables Market, By Value (2013-2023)
7.5.4 Saudi Arabia Injectables Market, By Indication, By Value (2013-2023)
7.5.5 Other Sterile Injectables Market, By Value (2013-2023)

8. Global Sterile Injectables Market Dynamics
8.1 Global Sterile Injectables Market Drivers
8.2 Global Sterile Injectables Market Restraints

9. Global Sterile Injectables Market Trends

10. Policy and Regulatory Landscape

11. Porter Five Force Analysis

12. SWOT Analysis

13. Company Profiles
13.1 Sanofi
13.2 Pfizer
13.3 Baxer International
13.4 Glaxosmithkline
13.5 Novartis
13.6 Gilead Sciences
13.7 Merck & Co.
13.8 Astra Zeneca